Low-Dose Aspirin or Nonsteroidal Anti-inflammatory Drug Use and Colorectal Cancer Risk

A recent comprehensive review concluded that additional research is needed to determine the optimal use of aspirin for cancer prevention.To assess associations between the use of low-dose aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) and colorectal cancer risk.Population-based, case-control study.Northern Denmark.Patients with first-time colorectal cancer in northern Denmark between 1994 and 2011. Population control participants...